Table 2. Mean (and standard deviation) of laboratory values.

Laboratory test	Baseline	4 Weeks	EOT	SVR12	Pt Diff	p-Value*
Platelet count (×1000 cells/μL)	143.4 ± 59.1	160.1 ± 65.6	159.9 ± 76.1	152.6 ± 67.5	9.2 (9.2)	0.054
Albumin (g/dL)	4.1 ± 1.2	4.1 ± 0.4	4.1 ± 0.4	4.1 ± 0.5	0 (0)	0.822
AST (U/L)	62.4 ± 79.5	25.0 ± 13.9	25.6 ± 20.3	28.2 ± 22.3	−34.3 (−34.3)	<0.001
ALT (U/L)	76.8 ± 126	25.2 ± 19.2	24.6 ± 21.7	27.6 ± 24.5	−49.3 (−49.3)	0.001
Total bilirubin (mg/dL)	0.8 ± 1.3	0.9 ± 0.7	0.9 ± 1.2	0.7 ± 0.9	−0.1 (−0.1)	0.453
Serum creatinine (mg/dL)†	1.3 ± 0.4	1.3 ± 0.4	1.3 ± 0.4	1.3 ± 0.4	0 (0)	0.514
Alkaline phosphatase (U/L)	129.5 ± 175.3	111.4 ± 176.7	99.6 ± 53.6	124.2 ± 134.7	−5.3 (−5.3)	0.694
Hemoglobin (g/dL)	12.8 ± 1.7	11.9 ± 2.3	12.0 ± 2.1	13.2 ± 1.8	0.3 (0.3)	0.033
In patients with RBV therapy	13.2 ± 1.3	11.5 ± 2.1	12.0 ± 1.7	13.4 ± 1.6	0.2 (0.2)	0.477
In patients without RBV therapy	12.5 ± 2.0	12.3 ± 2.5	12.1 ± 2.5	13.0 ± 2.0	0.5 (0.5)	0.017

Abbreviations: EOT, end of treatment; SVR12, sustained viral response at 12 weeks; AST, aspartate transaminase; ALT, alanine transaminase; Pt Diff, point difference.

^*Baseline vs. SVR12 paired t-test.

^†Patients on dialysis were not included in the calculation of mean and standard deviation for serum creatinine.